Invest in IPO
(initial public offering)

Unique opportunity to invest in company shares at offering price before they start trading on the exchange
Invest in IPO
SDHY PGIM Short Duration High Yield Opportunities Fund 25.11.2020 Invest in IPO
LIXT Lixte Biotechnology 25.11.2020 Invest in IPO
HEPA Hepion Pharmaceuticals, Inc 25.11.2020 Invest in IPO
NLSP NLS Pharmaceutics 03.12.2020 Invest in IPO
VVOS Vivos Therapeutics TBD Invest in IPO
Contact usCollapse

How to invest in IPO

Find an IPO
Our calendar contains the latest and most relevant information on initial public offerings.
Open MT5 Global account
Thousands of instruments for investing and trading.
Transfer funds to a trading account
Instant deposit and withdrawal in many convenient ways.
Apply for an IPO in the Private Office
Preliminary position will immediately appear in the portfolio.

IPO Calendar

SDHY
PGIM Short Duration High Yield Opportunities Fund
IPO
Anticipated date
25.11.2020
Anticipated price
$20 - $20

PGIM Short Duration High Yield Opportunities Fund, a Maryland statutory trust (the "Fund"), is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to provide total return, through a combination of current income and capital appreciation. There can be no guarantee that the Fund will achieve its investment objective or be able to structure its investment portfolio as anticipated.

LIXT
Lixte Biotechnology
Follow-on
Anticipated date
25.11.2020
Сlosing price
$4.75

Follow-On Uplisting: We are offering 1,500,000 units (each a “Unit”), each Unit consisting of one share of common stock, par value $0.0001 per share, and one warrant (each a “Warrant”) at an assumed price of $4.75 per Unit. Each Warrant is immediately exercisable, will entitle the holder to purchase one share of common stock at an exercise price of $5.70 and will expire five (5) years from the date of issuance. The shares of common stock and Warrants may be transferred separately immediately upon issuance. Our application for listing of our common stock and Warrants on The Nasdaq Capital Market has been approved subject to notice of issuance.

HEPA
Hepion Pharmaceuticals, Inc
Follow-on
Anticipated date
25.11.2020
Сlosing price
$2.89

FOLLOW-ON OFFERING: We are a biopharmaceutical company headquartered in Edison, New Jersey, focused on the development of pleiotropic drug therapy for treatment of chronic liver disease.

NLSP
NLS Pharmaceutics
IPO
Anticipated date
03.12.2020
Anticipated price
$5 - $6

We are an innovative biotechnology company engaged in the discovery and development of life-improving drug therapies to treat rare and complex central nervous system, or CNS, disorders, including narcolepsy, idiopathic hypersomnia, or IH, and other rare sleep disorders, as well as neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder, or ADHD. Pharmaceutics Ltd. is offering units, or Units, each consisting of one of our common shares and one Warrant to purchase one of our common shares, or, each, a Warrant, in an initial public offering.

VVOS
Vivos Therapeutics
IPO
Anticipated date
TBD
Anticipated price
$5 - $7

We are a revenue stage medical technology company focused on the development and commercialization of a highly differentiated technology offering a clinically effective non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).

ABNB
Airbnb
IPO
Anticipated date
TBD
Anticipated price
TBD

Airbnb has enabled home sharing at a global scale and created a new category of travel.

Get analytical
overview on IPO

* Required fields

HFEN
HF Enterprises
IPO
Anticipated date
24.11.2020
Anticipated price
$6 - $7

HF Enterprises Inc. is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operations in the United States, Singapore, Hong Kong, Australia and South Korea.

VMAR
Vision Marine Technologies
IPO
Anticipated date
24.11.2020
Anticipated price
$8 - $10

We are in the business of designing and manufacturing electric outboard powertrain systems and our related technology.

OZON.MM
Ozon Holdings Plc *
IPO
Anticipated date
24.11.2020
Anticipated price
$22.5 - $27.5

*Special terms and conditions: IPO of OZON will take place on the American stock exchange Nasdaq with the expected trading date of November 24. Issued American Depositary Shares (ISIN US69269L1044) will be also listed on the Moscow Exchange, so that the stock will be simultaneously traded on the Nasdaq and MOEX. Once the shares are allocated to the client's account, the instrument will be quoted in Russian rubles and by closing the position (selling shares) the client will make a trade on the Moscow Exchange with settlement in rubles.

The minimum order volume is 2000 USD, the LockUp period without the possibility of early sale is 4 trading days (can be increased).

LSAQ
Lifesci Acquisition II Corp.
IPO
Anticipated date
20.11.2020
Anticipated price
$10 - $10

LifeSci Acquisition II Corp., which we refer to as “we,” “us” or “our company,” is a newly organized blank check company incorporated in Delaware and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our “initial business combination.” Although we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination, we intend to focus on businesses that have their primary operations located in North America in the healthcare industry.

AUUD
Auddia, Inc
IPO
Anticipated date
12.11.2020
Anticipated price
$4.125 - $4.125

Unit Offering Consisting of One Share of Common Stock and One Series A Warrant to Purchase One Share of Common Stock. Auddia has developed technology, utilizing Artificial Intelligence (“AI”), to enable consumers to listen to existing AM/FM radio stations without commercials. By leveraging our legacy platform that served the commercial radio industry for seven years, and by deploying new artificial (AI) technologies that can identify and segment different units of audio content, we plan to bring to market a premium, subscription-based AM/FM radio listening experience through a downloadable app called AuddiaSM (the “Auddia App”).

AUVI
Applied UV, Inc
Follow-on
Anticipated date
06.11.2020
Сlosing price
$6

Develops, designs and manufactures disinfection systems, that eliminate pathogens that may cause healthcare-acquired infections (“HAIs”),

JUPW
Jupiter Wellness, Inc.
IPO
Anticipated date
23.10.2020
Anticipated price
$7.5 - $7.5

We are a cutting-edge wellness hemp-derived cannabidiol, or CBD, consumer product development company. We are in the early stage of manufacturing, distributing, and marketing a diverse line of consumer products infused with CBD. We are offering 1,000,000 units (each, a “Unit”), each Unit consisting of one share of common stock, par value $0.001 per share, and one warrant (each a “Warrant”), in a firm commitment initial public offering at an assumed price of US$7.50 per Unit.

INVO
INVO Bioscience
Follow-on
Anticipated date
23.10.2020
Сlosing price
$4.15

We are a medical device company focused on the Assisted Reproductive Technology (ART) marketplace. Our mission is to increase access to care and expand fertility treatment and patient care across the globe.

KRBP
Kiromic Biopharma
IPO
Anticipated date
16.10.2020
Anticipated price
$12 - $14

We are a target discovery and gene-editing company utilizing artificial intelligence and our proprietary neural network platform with a therapeutic focus on immuno-oncology.

PXSAP
Pyxis Tankers Inc
IPO
Anticipated date
08.10.2020
Anticipated price
$25 - $25

Unit offering: Each Consisting of One 7.75% Series A Cumulative Convertible Preferred Share and Eight Warrants

FAQ